Sustainable Egg Protein Onego Bio’s Bioalbumen offers a non-animal egg protein with identical amino acid sequence, enabling food manufacturers to market sustainable, allergen-conscious, and functionally versatile ingredients with roughly 90% lower environmental impact compared to traditional eggs.

Strategic Partnerships Recent collaborations with Sigma Foods and ongoing activity with The EVERY Company indicate strong interest from large-scale food players and potential co-development or procurement opportunities for bio-based egg proteins across bakery, dairy alternatives, and ready-to-eat products.

Global Expansion Expansion into Wisconsin signals a push to scale U.S. production capacity, presenting opportunities to supply North American manufacturers with near-term Bioalbumen ingredients and reduce supply chain risk for egg-reliant products.

IP and Litigation Active IP-related litigation and sanctions discussions with EVERY Co suggest a competitive landscape and potential need for differentiated contracts, protective IP terms, and proactive diligence when engaging in co-development or licensing discussions.

Financial Growth Potential With revenue in the low single-digit millions yet a substantial funding stance (approximately $73M) and a growing partner ecosystem, there is room to position Bioalbumen in multi-year, multi-site supply deals and strategic collaborations with major food manufacturers seeking stable egg alternatives.